Literature DB >> 23143728

Epilepsy surgery for early infantile epileptic encephalopathy (ohtahara syndrome).

Saleem I Malik1, Carlos A Galliani, Angel W Hernandez, David J Donahue.   

Abstract

Early infantile epileptic encephalopathy or Ohtahara syndrome is the earliest form of the age-dependent epileptic encephalopathies. Its manifestations include tonic spasms, focal motor seizures, suppression burst pattern, pharmaco-resistance, and dismal prognosis. The purpose of this study was to evaluate the effectiveness of epilepsy surgery in selected infants. We identified 11 patients, 9 from the literature and 2 from our institution that fulfilled diagnostic criteria of Ohtahara syndrome and had undergone epilepsy surgery in infancy. Seven of the 11 infants have remained seizure free (Engel class IA) and four are reportedly having rare to infrequent seizures (Engel class IIB). All patients experienced "catch up" development. In contrast to Ohtahara's15 pharmacotherapy managed patients, who had a mortality rate of approximately fifty percent, and those that survived continued to have seizures and were severely impaired, the outcome of selected surgically managed patients is much more favorable.

Entities:  

Keywords:  Early infantile epileptic encephalopathy; Ohtahara syndrome; cortical resection; epilepsy surgery; suppression bursts

Mesh:

Year:  2012        PMID: 23143728     DOI: 10.1177/0883073812464395

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

1.  Diagnosis and management of epileptic encephalopathies in children.

Authors:  Puneet Jain; Suvasini Sharma; Manjari Tripathi
Journal:  Epilepsy Res Treat       Date:  2013-07-22

Review 2.  Emerging role of the KCNT1 Slack channel in intellectual disability.

Authors:  Grace E Kim; Leonard K Kaczmarek
Journal:  Front Cell Neurosci       Date:  2014-07-28       Impact factor: 5.505

3.  Diffusion Tensor Imaging in an Infant Undergoing Functional Hemispherectomy: A Surgical Aid.

Authors:  Allen L Ho; Arjun V Pendharkar; Eric S Sussman; May Casazza; Gerald A Grant
Journal:  Cureus       Date:  2017-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.